SCHEMBL757069

SCHEMBL757069

Cn1nc(C(F)(F)F)cc1S(C)(=O)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.47
NPC1 O15118 2/20 0.47
PTGS2 P35354 7/20 0.43
PTGS1 P23219 2/20 0.42
CYP2C9 P11712 1/20 0.42
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX5 P09917 1/20 0.40
CTSK P43235 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464891 0.87 RAB9A (0.43) RAB9ANPC1PTGS2PTGS1CYP2C9
SCHEMBL21216289 0.84 RAB9A (0.42) RAB9ANPC1PTGS2PTGS1CYP2C9
SCHEMBL1459707 0.77 KMT2A (0.45) RAB9ANPC1PTGS2PTGS1CYP2C9
SCHEMBL26066108 0.77 MAPT (0.40) RAB9ANPC1PTGS2PTGS1ALDH1A1
SCHEMBL27070071 0.77 KMT2A (0.40) RAB9ANPC1PTGS2PTGS1ALDH1A1
SCHEMBL760108 0.77 LMNA (0.40) PTGS2PTGS1CYP2C9ALDH1A1HSD17B10
SCHEMBL946905 0.75 KMT2A (0.45) RAB9ANPC1PTGS2PTGS1CYP2C9
SCHEMBL2262355 0.75 RAB9A (0.42) RAB9ANPC1PTGS2PTGS1ALDH1A1
SCHEMBL25372284 0.74 KDM4E (0.34) RAB9ANPC1ALDH1A1HSD17B10CYP3A4
SCHEMBL16487838 0.74 PTGS1 (0.51) RAB9ANPC1PTGS2PTGS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 WO disclosed
CN-101511818-B N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA AGRITECHNO CO LTD 2013-05-08 CN disclosed
EP-2050745-B1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA AGRITECHNO CO LTD (JP) 2012-03-21 EP disclosed
US-7994094-B2 N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA AGRITECHNO CO., LTD. (JP) 2011-08-09 US disclosed
US-7994094-B2 N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA AGRITECHNO CO., LTD. (JP) 2011-08-09 US disclosed
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA CHEMICAL CO., LTD. (JP) 2010-06-03 US disclosed
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT OTSUKA CHEMICAL CO., LTD. (JP) 2010-06-03 US disclosed
CN-101511818-A N-pyridylpiperidine compound, method for producing the same, and pest control agent OTSUKA CHEMICAL CO LTD (JP) 2009-08-19 CN disclosed
EP-2050745-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT Otsuka Chemical Co., Ltd. (JP) 2009-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137582-A1 N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THE SAME, AND PEST CONTROL AGENT HRH4, NOX4, PRDX4 RAB9A 151/4885NPC1 2296/4885PTGS2 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.